Could the gut microbiome be a new therapeutic target for multiple sclerosis?

Source EurekAlert:

New Rochelle, NY, July 6, 2016–An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut,  sparking new research on the gut microbiome as a potential target for MS treatment and prevention.  Read on